Characterization of the human cysteinyl leukotriene CysLT1 receptor

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Nature

• Publication date

  1999-06-24

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/21658PMID 10391245
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Leukotriene Binding, Signaling, and Analysis of HIV Coreceptor Function in Mouse and Human Leukotriene B4Receptor-transfected Cells*

  1999cited by this paper
• Montelukast for chronic asthma in 6- to 14-year-old children: a randomized, double-blind trial. Pediatric Montelukast Study Group.

  1999cited by this paper
• An automated aequorin luminescence-based functional calcium assay for G-protein-coupled receptors.

  1999cited by this paper
• Montelukast for Chronic Asthma in 6- to 14-Year-Old Children A Randomized, Double-blind Trial

  1998cited by this paper
• Molecular Characterization and Expression of Cloned Human Galanin Receptors GALR2 and GALR3

  1998cited by this paper
• Characterization of a receptor subtype-selective lysophosphatidic acid mimetic.

  1998cited by this paper
• Montelukast, a leukotriene-receptor antagonist, for the treatment of mild asthma and exercise-induced bronchoconstriction.

  1998cited by this paper
• Montelukast, a once-daily leukotriene receptor antagonist, in the treatment of chronic asthma: a multicenter, randomized, double-blind trial. Montelukast Clinical Research Study Group.

  1998cited by this paper
• Characterization of the recombinant human prostanoid DP receptor and identification of L‐644,698, a novel selective DP agonist

  1998cited by this paper
• Results of the first U.S. double-blind, placebo-controlled, multicenter clinical study in asthma with pranlukast, a novel leukotriene receptor antagonist.

  1997cited by this paper
• A G-protein-coupled receptor for leukotriene B4 that mediates chemotaxis

  1997cited by this paper
• Effectiveness of the Leukotriene Receptor Antagonist Zafirlukast for Mild-to-Moderate Asthma

  1997cited by this paper
• Melanophore pigment dispersion responses to agonists show two patterns of sensitivity to inhibitors of cAMP‐dependent protein kinase and protein kinase C

  1996cited by this paper
• Pharmacology of montelukast sodium (Singulair), a potent and selective leukotriene D4 receptor antagonist.

  1995cited by this paper
• Prostanoid and leukotriene receptors: a progress report from the IUPHAR working parties on classification and nomenclature.

  1995cited by this paper
• Leukotriene receptors.

  1995cited by this paper
• Leukotriene D4-induced increases in cytosolic calcium in THP-1 cells: dependence on extracellular calcium and inhibition with selective leukotriene D4 receptor antagonists.

  1994cited by this paper
• Functional expression and characterization of human D2 and D3 dopamine receptors

  1994cited by this paper
• Responses to sphingosine-1-phosphate in X. laevis oocytes: similarities with lysophosphatidic acid signaling.

  1993cited by this paper
• Characterization of the leukotriene D4 receptor in dimethylsulphoxide-differentiated U937 cells: comparison with the leukotriene D4 receptor in human lung and guinea-pig lung.

  1993cited by this paper
• Photoaffinity labeling of the leukotriene D4 receptor in guinea pig lung.

  1993cited by this paper
• A second cysteinyl leukotriene receptor in human lung.

  1992cited by this paper
• Leukotrienes and other products of the 5-lipoxygenase pathway. Biochemistry and relation to pathobiology in human diseases.

  1990cited by this paper
• Pharmacology of L-660,711 (MK-571): a novel potent and selective leukotriene D4 receptor antagonist.

  1989cited by this paper
• Improved tools for biological sequence comparison.

  1988cited by this paper
• Effects of l‐serine borate on antagonism of leukotriene C4‐induced contractions of guinea‐pig trachea

  1987cited by this paper
• Formation and actions of leukotrienes.

  1984cited by this paper
• Leukotrienes are potent constrictors of human bronchi

  1980cited by this paper

• Effect of ONO-6950, a novel dual cysteinyl leukotriene 1 and 2 receptor antagonist, in guinea pig models of allergic rhinitis.

  2026cites this paper
• Structural basis of the cysteinyl leukotriene receptor type 2 activation by LTD4

  2025cites this paper
• Discovery of GJG057, a Potent and Highly Selective Inhibitor of Leukotriene C4 Synthase.

  2025cites this paper
• Molecular insights into ago-allosteric modulation at cysteinyl leukotriene receptor 2

  2025influential citation
• Genetic variants of accessory proteins and G proteins in human genetic disease

  2025cites this paper
• Leukotrienes: Bridging the Inflammatory Gap in Asthma and Inflammatory Bowel Diseases (IBD)

  2025cites this paper
• Leukotriene receptors in GtoPdb v.2025.3

  2025cites this paper
• Molecular insights into ligand recognition and signaling of OXGR1

  2025cites this paper
• The screened triterpene acids from Loquat fruit by CysLTR1-immobilized column could serve as alternative anti-inflammatory agents

  2025cites this paper
• Development of Zafirlukast Analogues for Improved Antithrombotic Activity Through Thiol Isomerase Inhibition

  2025cites this paper
• GPR17 - orphan G protein-coupled receptor with therapeutic potential.

  2025cites this paper
• Mast cell-specific CysLT2 receptor signaling inhibits cysteinyl leukotriene-dependent mast cell activation and type 2 allergic lung inflammation

  2025cites this paper
• Differential expression of eicosanoid pathways after whole blood stimulation in asthma patients

  2025cites this paper
• Unraveling cysteinyl leukotrienes and their receptors in inflammation through the brain-gut-lung axis

  2025cites this paper
• Montelukast: A Scientific and Legal Review.

  2025cites this paper
• The ADCY1-mediated cAMP signaling pathway mediates functional effects of montelukast treatment in brain organoids

  2025cites this paper
• Cysteinyl leukotriene receptor-1 as a potential target for host-directed therapy during chronic schistosomiasis in murine model

  2024cites this paper
• Cysteinyl Leukotrienes in Allergic Inflammation.

  2024cites this paper
• Research progress of knee fibrosis after anterior cruciate ligament reconstruction

  2024cites this paper
• Neuromodulatory Effects of Leukotriene receptor antagonists: A comprehensive review.

  2024cites this paper
• Leukotriene receptors in GtoPdb v.2023.1 Leukotriene receptors in GtoPdb v.2023.1

  2023cites this paper
• Bioactive lipid regulation of platelet function, hemostasis, and thrombosis.

  2023cites this paper
• Structural diversity of leukotriene G-protein coupled receptors

  2023influential citation
• Markhamia lutea leaves aqueous and ethanolic extract with curative anti-inflammatory activity attenuates paclitaxel toxicity in rat’s intestine

  2023cites this paper
• Synthesis and Significance of Arachidonic Acid, a Substrate for Cyclooxygenases, Lipoxygenases, and Cytochrome P450 Pathways in the Tumorigenesis of Glioblastoma Multiforme, Including a Pan-Cancer Comparative Analysis

  2023influential citation
• Distribution of the cysteinyl leukotriene system components in the human, rat and mouse eye.

  2023cites this paper
• Intestinal Lymphatic Dysfunction in Kidney Disease

  2023cites this paper
• The tumor promoter cysteinyl leukotriene receptor 1 regulates PD-L1 expression in colon cancer cells via the Wnt/β-catenin signaling axis

  2023influential citation
• Effects of non‐steroidal anti‐inflammatory drugs and other eicosanoid pathway modifiers on antiviral and allergic responses: EAACI task force on eicosanoids consensus report in times of COVID‐19

  2022cites this paper
• Leukotrienes vs. Montelukast—Activity, Metabolism, and Toxicity Hints for Repurposing

  2022cites this paper
• Blockade of Platelet CysLT1R Receptor with Zafirlukast Counteracts Platelet Protumoral Action and Prevents Breast Cancer Metastasis to Bone and Lung

  2022influential citation
• Leukotriene D4 accelerates antigen-mediated mast cell responses via the cysteinyl leukotriene 1 receptor.

  2022cites this paper
• A Dual Role for Cysteinyl Leukotriene Receptors in the Pathogenesis of Corneal Infection

  2022cites this paper
• Structures of oxysterol sensor EBI2/GPR183, a key regulator of the immune response.

  2022cites this paper
• A SWELL time to develop the molecular pharmacology of the volume-regulated anion channel (VRAC)

  2022cites this paper
• Zafirlukast Induces VHL- and HIF-2α-Dependent Oxidative Cell Death in 786-O Clear Cell Renal Carcinoma Cells

  2022cites this paper
• Anti-leukotriene drugs in the therapy of inflammatory diseases

  2022cites this paper
• Association between Glucose-6-Phosphate Dehydrogenase Deficiency and Asthma

  2021cites this paper
• Tuft cell-produced cysteinyl leukotrienes and IL-25 synergistically initiate lung type 2 inflammation

  2021influential citation
• Targeting Mammalian 5-Lipoxygenase by Dietary Phenolics as an Anti-Inflammatory Mechanism: A Systematic Review

  2021cites this paper
• Targeting the OXE receptor with a selective antagonist inhibits allergen‐induced pulmonary inflammation in non‐human primates

  2021cites this paper
• Leukotriene D4 Upregulates Oxidized Low-Density Lipoprotein Receptor 1 and CD36 to Enhance Oxidized LDL Uptake and Phagocytosis in Macrophages Through Cysteinyl Leukotriene Receptor 1

  2021influential citation
• Inhibition of the cysteinyl leukotriene pathways increases survival of RGCs and reduces microglial activation in ocular hypertension.

  2021cites this paper
• Leukotriene C4 synthase is a novel PPARγ target gene, and leukotriene C4 and D4 activate adipogenesis through cysteinyl LT1 receptors in adipocytes.

  2021cites this paper
• Pharmacological Management of Asthma and COPD

  2021cites this paper
• Eicosanoid receptors as therapeutic targets for asthma.

  2021cites this paper
• Role of eicosanoids in liver repair, regeneration and cancer.

  2021cites this paper
• The Leukotriene Receptor Antagonist Montelukast Attenuates Neuroinflammation and Affects Cognition in Transgenic 5xFAD Mice

  2021cites this paper
• Bioactive lipids and cancer metastasis to bone

  2021cites this paper
• Cysteinyl leukotriene induces eosinophil extracellular trap formation via cysteinyl leukotriene 1 receptor in a murine model of asthma

  2021cites this paper
• Classification models and SAR analysis on CysLT1 receptor antagonists using machine learning algorithms

  2021cites this paper
• The CysLT2R receptor mediates leukotriene C4-driven acute and chronic itch

  2021cites this paper
• Emerging role of cysteinyl LTs in cancer

  2021influential citation
• The oxysterome and its receptors as pharmacological targets in inflammatory diseases

  2021cites this paper
• Mechanistic insight on the role of leukotriene receptors in ischemic–reperfusion injury

  2021cites this paper
• A review of non-prostanoid, eicosanoid receptors: expression, characterization, regulation, and mechanism of action

  2021cites this paper
• Untapped Potential: Therapeutically Targeting Eicosanoids and Endocannabinoids in the Lung

  2021cites this paper
• Biologically active lipids in the regulation of lymphangiogenesis in disease states.

  2021cites this paper
• Montelukast alleviates inflammation in experimental autoimmune encephalomyelitis by altering Th17 differentiation in a mouse model

  2021cites this paper
• Potential Effects of Leukotriene Receptor Antagonist Montelukast in Treatment of Neuroinflammation in Parkinson’s Disease

  2021cites this paper
• Integral membrane enzymes in eicosanoid metabolism: Structures, mechanisms and inhibitor design.

  2020cites this paper
• Leukotriene receptors (version 2020.3) in the IUPHAR/BPS Guide to Pharmacology Database

  2020cites this paper
• Montelukast use over the past 20 years: monitoring of its effects and safety issues

  2020cites this paper
• Druggable Lipid Signaling Pathways

  2020cites this paper
• Druggable Lipid GPCRs: Past, Present, and Prospects.

  2020cites this paper
• Tumour suppressor 15-hydroxyprostaglandin dehydrogenase induces differentiation in colon cancer via GLI1 inhibition

  2020cites this paper
• High Cysteinyl Leukotriene Receptor 1 Expression Correlates with Poor Survival of Uveal Melanoma Patients and Cognate Antagonist Drugs Modulate the Growth, Cancer Secretome, and Metabolism of Uveal Melanoma Cells

  2020cites this paper
• Leukotriene D4 role in allergic asthma pathogenesis from cellular and therapeutic perspectives.

  2020cites this paper
• A simple and sensitive HPLC-MS/MS assay for the quantitation of montelukast in cell-based systems in vitro pulmonary drug permeability study.

  2020cites this paper
• Improved Bioavailability of Montelukast through a Novel Oral Mucoadhesive Film in Humans and Mice

  2020cites this paper
• Cellular Source of Cysteinyl Leukotrienes following Chlorine Exposure.

  2020cites this paper
• CysLT1 receptor signaling and the tumor microenvironment in colon cancer models

  2020cites this paper
• Regulation of blood flow in small arteries: mechanosensory events underlying myogenic vasoconstriction

  2020cites this paper
• The Role of Arachidonic Acid Metabolism in Myocardial Ischemia–Reperfusion Injury

  2020cites this paper
• Targeting the OXE receptor as a potential novel therapy for asthma.

  2020cites this paper
• 5-lipoxygenase pathway and its downstream cysteinyl leukotrienes as potential therapeutic targets for Alzheimer's disease.

  2020cites this paper
• Current perspective on eicosanoids in asthma and allergic diseases: EAACI Task Force consensus report, part I

  2020cites this paper
• Tuft-Cell-Derived Leukotrienes Drive Rapid Anti-helminth Immunity in the Small Intestine but Are Dispensable for Anti-protist Immunity.

  2020cites this paper
• MK-571, a Cysteinyl Leukotriene Receptor 1 Antagonist, Inhibits Hepatitis C Virus Replication

  2020cites this paper
• Phase 2 trial of montelukast for prevention of pain in sickle cell disease.

  2020cites this paper
• Current perspective on eicosanoids in and allergic diseases - EAACI Task Force consensus report, part

  2020cites this paper
• G Protein–Coupled Receptors in Asthma Therapy: Pharmacology and Drug Action

  2020cites this paper
• The Leukotriene Receptor Antagonist Montelukast as a Potential COVID-19 Therapeutic

  2020cites this paper
• Leukotriene D4 Paradoxically Limits LTC4 Driven Platelet Activation and Lung Immunopathology.

  2020cites this paper
• Microglia depletion diminishes key elements of the leukotriene pathway in the brain of Alzheimer’s Disease mice

  2020cites this paper
• Cysteinyl leukotriene receptor 1 promotes 5-fluorouracil resistance and resistance-derived stemness in colon cancer cells.

  2020cites this paper
• Review of montelukast use over the past 20 years and monitoring of its effects Running title: Montelukast in wheezy children

  2020cites this paper
• A Case for Montelukast in COVID-19: "The use of Computational Docking to estimate the effects of Montelukast on potential viral main protease catalytic site"

  2020cites this paper
• Investigation of the relationship between chronic montelukast treatment, asthma and depression-like behavior in mice

  2020cites this paper
• Structural basis of ligand selectivity and disease mutations in cysteinyl leukotriene receptors

  2019cites this paper
• Role of Protein Tyrosine Phosphatase Epsilon (PTPε) in Leukotriene D4-Induced CXCL8 Expression

  2019cites this paper
• Developmental perspectives of the drugs targeting enzyme-instigated inflammation: a mini review

  2019cites this paper
• Directed Non-targeted Mass Spectrometry and Chemical Networking for Discovery of Eicosanoids and Related Oxylipins.

  2019cites this paper
• Lipid mediators in immune regulation and resolution

  2019cites this paper
• Current state and future prospect of the therapeutic strategy targeting cysteinyl leukotriene metabolism in asthma.

  2019cites this paper
• COX‐1 mediates IL‐33–induced extracellular signal‐regulated kinase activation in mast cells: Implications for aspirin sensitivity

  2019cites this paper
• How to use NSAIDs for patients with nasal polyps

  2019cites this paper
• Cysteinyl Leukotriene Receptor 2 Drives Lung Immunopathology Through a Platelet and High Mobility Box 1-Dependent Mechanism

  2019cites this paper
• Proinflammatory Pathways in the Pathogenesis of Asthma.

  2019cites this paper
• Leukotriene receptors (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database

  2019cites this paper